ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 58575 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 58575; 2) Community: the network communities that were significantly associated with the response to NSC 58575; 3) Molecule: the relationships between components within communities and NSC 58575; 4) MDR: the compounds that were significantly associated with the NSC 58575.

NSC Compound Enrichment Correlation
NSC 109825 Null 0.0467178916101838 -0.10110826
NSC 11668 N4,N6-bis(3-chlorophenyl)-1-methyl-1H-pyrazolo[3,4-d]pyrimidine-4,6-diamine 0.0467178916101838 0.42369351
NSC 137765 Ethanesulfonic acid, compd. with 3-(4,6-diamino-2,2-dimethyl-1,3,5-triazin-1(2H)-yl)-N-phenylbenzeneacetamide (1:1) 0.0467178916101838 0.16750983
NSC 145219 Null 0.0467178916101838 0.42834502
NSC 158036 1,2-Benzisothiazoline-3-thione, 2-methyl- (8CI) 0.0467178916101838 0.49605969
NSC 175630 Toyocamycin, 6-amino- 0.0467178916101838 0.49933223
NSC 302325 2,4-Pyrimidinediamine, 5-(4-chloro-3-nitrophenyl)-6-ethyl- 0.0467178916101838 0.31541409
NSC 328403 Acetamide, N-(4-formyl-5,6,7,9-tetrahydro-1,2,3,10- tetramethoxy-9-oxobenzo[a]heptalen-7-yl)-, (S)- 0.0467178916101838 0.28812436
NSC 351710 2-methylellpticinium 0.0467178916101838 -0.38399471
NSC 357680 BUELLOLIDE 0.0467178916101838 0.38926649
Total:99  Current:94    [First] [Prev] [Next] [Last]